Alyeska Investment Group
BHVN

Alyeska Investment Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Alyeska Investment Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
2022
Q1 		$6.22M Buy
2021
Q4 		– Sell
2021
Q3 		$8.47M Buy
2020
Q1 		– Sell
2019
Q4 		$3.32M Buy
2019
Q3 		$2.12M Sell
2019
Q2 		$8.55M Buy
2017
Q3 		– Sell
2017
Q2 		$3.74M Buy